nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Nephropathy—Rosuvastatin—atherosclerosis	0.0472	0.0484	CcSEcCtD
Procaine—Laryngeal oedema—Niacin—atherosclerosis	0.0255	0.0262	CcSEcCtD
Procaine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.0153	0.0157	CcSEcCtD
Procaine—Neuropathy—Pravastatin—atherosclerosis	0.0151	0.0155	CcSEcCtD
Procaine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0143	0.0147	CcSEcCtD
Procaine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0129	0.0133	CcSEcCtD
Procaine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.0123	0.0126	CcSEcCtD
Procaine—Eosinophilia—Lovastatin—atherosclerosis	0.0118	0.0121	CcSEcCtD
Procaine—Eosinophilia—Ezetimibe—atherosclerosis	0.0116	0.0119	CcSEcCtD
Procaine—Eosinophilia—Simvastatin—atherosclerosis	0.0111	0.0114	CcSEcCtD
Procaine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.0104	0.0107	CcSEcCtD
Procaine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.0102	0.0105	CcSEcCtD
Procaine—Eosinophilia—Pravastatin—atherosclerosis	0.01	0.0103	CcSEcCtD
Procaine—Sweating increased—Pravastatin—atherosclerosis	0.00984	0.0101	CcSEcCtD
Procaine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00977	0.01	CcSEcCtD
Procaine—Angioedema—Rosuvastatin—atherosclerosis	0.00897	0.00921	CcSEcCtD
Procaine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00883	0.00906	CcSEcCtD
Procaine—Chills—Lovastatin—atherosclerosis	0.00858	0.00881	CcSEcCtD
Procaine—Arthralgia—Rosuvastatin—atherosclerosis	0.00836	0.00858	CcSEcCtD
Procaine—Erythema—Ezetimibe—atherosclerosis	0.00816	0.00838	CcSEcCtD
Procaine—Chills—Simvastatin—atherosclerosis	0.00802	0.00824	CcSEcCtD
Procaine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00785	0.00806	CcSEcCtD
Procaine—Vision blurred—Lovastatin—atherosclerosis	0.00784	0.00805	CcSEcCtD
Procaine—Tremor—Lovastatin—atherosclerosis	0.0078	0.00801	CcSEcCtD
Procaine—Erythema—Simvastatin—atherosclerosis	0.00779	0.00799	CcSEcCtD
Procaine—Tinnitus—Niacin—atherosclerosis	0.00766	0.00786	CcSEcCtD
Procaine—Angioedema—Lovastatin—atherosclerosis	0.00761	0.00781	CcSEcCtD
Procaine—Tinnitus—Pravastatin—atherosclerosis	0.00754	0.00774	CcSEcCtD
Procaine—Angioedema—Ezetimibe—atherosclerosis	0.00746	0.00766	CcSEcCtD
Procaine—Leukopenia—Lovastatin—atherosclerosis	0.00745	0.00765	CcSEcCtD
Procaine—Chills—Niacin—atherosclerosis	0.00737	0.00756	CcSEcCtD
Procaine—Vision blurred—Simvastatin—atherosclerosis	0.00734	0.00753	CcSEcCtD
Procaine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.0073	0.0075	CcSEcCtD
Procaine—Tremor—Simvastatin—atherosclerosis	0.00729	0.00749	CcSEcCtD
Procaine—Chills—Pravastatin—atherosclerosis	0.00726	0.00745	CcSEcCtD
Procaine—Erythema—Niacin—atherosclerosis	0.00715	0.00734	CcSEcCtD
Procaine—Angioedema—Simvastatin—atherosclerosis	0.00711	0.0073	CcSEcCtD
Procaine—Arthralgia—Lovastatin—atherosclerosis	0.00709	0.00728	CcSEcCtD
Procaine—Anxiety—Lovastatin—atherosclerosis	0.00706	0.00725	CcSEcCtD
Procaine—Hypertension—Ezetimibe—atherosclerosis	0.00705	0.00724	CcSEcCtD
Procaine—Tension—Niacin—atherosclerosis	0.00702	0.0072	CcSEcCtD
Procaine—Leukopenia—Simvastatin—atherosclerosis	0.00697	0.00715	CcSEcCtD
Procaine—Arthralgia—Ezetimibe—atherosclerosis	0.00695	0.00714	CcSEcCtD
Procaine—Nervousness—Niacin—atherosclerosis	0.00694	0.00713	CcSEcCtD
Procaine—Tension—Pravastatin—atherosclerosis	0.00691	0.00709	CcSEcCtD
Procaine—Nervousness—Pravastatin—atherosclerosis	0.00684	0.00702	CcSEcCtD
Procaine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00679	0.00697	CcSEcCtD
Procaine—Vision blurred—Niacin—atherosclerosis	0.00674	0.00692	CcSEcCtD
Procaine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00666	0.00684	CcSEcCtD
Procaine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00665	0.00683	CcSEcCtD
Procaine—Vision blurred—Pravastatin—atherosclerosis	0.00663	0.00681	CcSEcCtD
Procaine—Arthralgia—Simvastatin—atherosclerosis	0.00663	0.0068	CcSEcCtD
Procaine—Anxiety—Simvastatin—atherosclerosis	0.00661	0.00678	CcSEcCtD
Procaine—Tremor—Pravastatin—atherosclerosis	0.00659	0.00677	CcSEcCtD
Procaine—Angioedema—Niacin—atherosclerosis	0.00653	0.00671	CcSEcCtD
Procaine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00652	0.0067	CcSEcCtD
Procaine—Angioedema—Pravastatin—atherosclerosis	0.00643	0.0066	CcSEcCtD
Procaine—Syncope—Niacin—atherosclerosis	0.00641	0.00658	CcSEcCtD
Procaine—Leukopenia—Niacin—atherosclerosis	0.0064	0.00657	CcSEcCtD
Procaine—Urticaria—Rosuvastatin—atherosclerosis	0.00637	0.00654	CcSEcCtD
Procaine—Oedema—Simvastatin—atherosclerosis	0.00635	0.00652	CcSEcCtD
Procaine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00635	0.00652	CcSEcCtD
Procaine—Leukopenia—Pravastatin—atherosclerosis	0.0063	0.00647	CcSEcCtD
Procaine—Loss of consciousness—Niacin—atherosclerosis	0.00628	0.00645	CcSEcCtD
Procaine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00622	0.00639	CcSEcCtD
Procaine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00619	0.00635	CcSEcCtD
Procaine—Arthralgia—Niacin—atherosclerosis	0.00609	0.00625	CcSEcCtD
Procaine—Hypertension—Pravastatin—atherosclerosis	0.00608	0.00624	CcSEcCtD
Procaine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00607	0.00623	CcSEcCtD
Procaine—Arthralgia—Pravastatin—atherosclerosis	0.00599	0.00615	CcSEcCtD
Procaine—Anxiety—Pravastatin—atherosclerosis	0.00597	0.00613	CcSEcCtD
Procaine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00591	0.00606	CcSEcCtD
Procaine—Fatigue—Lovastatin—atherosclerosis	0.00586	0.00601	CcSEcCtD
Procaine—Anaphylactic shock—Niacin—atherosclerosis	0.00583	0.00599	CcSEcCtD
Procaine—Oedema—Niacin—atherosclerosis	0.00583	0.00599	CcSEcCtD
Procaine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00579	0.00594	CcSEcCtD
Procaine—Oedema—Pravastatin—atherosclerosis	0.00574	0.0059	CcSEcCtD
Procaine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00574	0.0059	CcSEcCtD
Procaine—Fatigue—Ezetimibe—atherosclerosis	0.00574	0.0059	CcSEcCtD
Procaine—Shock—Niacin—atherosclerosis	0.00574	0.00589	CcSEcCtD
Procaine—Tachycardia—Niacin—atherosclerosis	0.00569	0.00585	CcSEcCtD
Procaine—Pruritus—Rosuvastatin—atherosclerosis	0.00567	0.00582	CcSEcCtD
Procaine—Hyperhidrosis—Niacin—atherosclerosis	0.00564	0.00579	CcSEcCtD
Procaine—Thrombocytopenia—Pravastatin—atherosclerosis	0.00562	0.00577	CcSEcCtD
Procaine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00555	0.0057	CcSEcCtD
Procaine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00548	0.00563	CcSEcCtD
Procaine—Fatigue—Simvastatin—atherosclerosis	0.00548	0.00562	CcSEcCtD
Procaine—Hypotension—Niacin—atherosclerosis	0.00545	0.0056	CcSEcCtD
Procaine—Urticaria—Lovastatin—atherosclerosis	0.0054	0.00554	CcSEcCtD
Procaine—Body temperature increased—Lovastatin—atherosclerosis	0.00537	0.00551	CcSEcCtD
Procaine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00532	0.00546	CcSEcCtD
Procaine—Dizziness—Rosuvastatin—atherosclerosis	0.0053	0.00544	CcSEcCtD
Procaine—Urticaria—Ezetimibe—atherosclerosis	0.00529	0.00543	CcSEcCtD
Procaine—Body temperature increased—Ezetimibe—atherosclerosis	0.00527	0.00541	CcSEcCtD
Procaine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00523	0.00537	CcSEcCtD
Procaine—Somnolence—Niacin—atherosclerosis	0.00519	0.00533	CcSEcCtD
Procaine—Rash—Rosuvastatin—atherosclerosis	0.00505	0.00519	CcSEcCtD
Procaine—Dermatitis—Rosuvastatin—atherosclerosis	0.00505	0.00518	CcSEcCtD
Procaine—Urticaria—Simvastatin—atherosclerosis	0.00505	0.00518	CcSEcCtD
Procaine—Body temperature increased—Simvastatin—atherosclerosis	0.00502	0.00516	CcSEcCtD
Procaine—Hypersensitivity—Lovastatin—atherosclerosis	0.005	0.00514	CcSEcCtD
Procaine—Fatigue—Pravastatin—atherosclerosis	0.00495	0.00508	CcSEcCtD
Procaine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00491	0.00504	CcSEcCtD
Procaine—Pruritus—Lovastatin—atherosclerosis	0.00481	0.00493	CcSEcCtD
Procaine—Nausea—Rosuvastatin—atherosclerosis	0.00476	0.00489	CcSEcCtD
Procaine—Pruritus—Ezetimibe—atherosclerosis	0.00471	0.00484	CcSEcCtD
Procaine—Hypersensitivity—Simvastatin—atherosclerosis	0.00468	0.00481	CcSEcCtD
Procaine—Diarrhoea—Lovastatin—atherosclerosis	0.00465	0.00477	CcSEcCtD
Procaine—Urticaria—Niacin—atherosclerosis	0.00463	0.00476	CcSEcCtD
Procaine—Body temperature increased—Niacin—atherosclerosis	0.00461	0.00474	CcSEcCtD
Procaine—Urticaria—Pravastatin—atherosclerosis	0.00456	0.00469	CcSEcCtD
Procaine—Diarrhoea—Ezetimibe—atherosclerosis	0.00456	0.00468	CcSEcCtD
Procaine—Body temperature increased—Pravastatin—atherosclerosis	0.00454	0.00466	CcSEcCtD
Procaine—Pruritus—Simvastatin—atherosclerosis	0.0045	0.00462	CcSEcCtD
Procaine—Dizziness—Lovastatin—atherosclerosis	0.00449	0.00461	CcSEcCtD
Procaine—Dizziness—Ezetimibe—atherosclerosis	0.00441	0.00452	CcSEcCtD
Procaine—Diarrhoea—Simvastatin—atherosclerosis	0.00435	0.00446	CcSEcCtD
Procaine—Vomiting—Lovastatin—atherosclerosis	0.00432	0.00443	CcSEcCtD
Procaine—BCHE—Irinotecan Pathway—NPC1—atherosclerosis	0.0043	0.19	CbGpPWpGaD
Procaine—Hypersensitivity—Niacin—atherosclerosis	0.0043	0.00441	CcSEcCtD
Procaine—Rash—Lovastatin—atherosclerosis	0.00428	0.0044	CcSEcCtD
Procaine—Dermatitis—Lovastatin—atherosclerosis	0.00428	0.00439	CcSEcCtD
Procaine—Vomiting—Ezetimibe—atherosclerosis	0.00424	0.00435	CcSEcCtD
Procaine—Hypersensitivity—Pravastatin—atherosclerosis	0.00423	0.00435	CcSEcCtD
Procaine—Dizziness—Simvastatin—atherosclerosis	0.0042	0.00431	CcSEcCtD
Procaine—Rash—Ezetimibe—atherosclerosis	0.0042	0.00431	CcSEcCtD
Procaine—Dermatitis—Ezetimibe—atherosclerosis	0.0042	0.00431	CcSEcCtD
Procaine—Pruritus—Niacin—atherosclerosis	0.00413	0.00424	CcSEcCtD
Procaine—Pruritus—Pravastatin—atherosclerosis	0.00406	0.00417	CcSEcCtD
Procaine—Vomiting—Simvastatin—atherosclerosis	0.00404	0.00415	CcSEcCtD
Procaine—Nausea—Lovastatin—atherosclerosis	0.00404	0.00414	CcSEcCtD
Procaine—Rash—Simvastatin—atherosclerosis	0.00401	0.00411	CcSEcCtD
Procaine—Dermatitis—Simvastatin—atherosclerosis	0.004	0.00411	CcSEcCtD
Procaine—Diarrhoea—Niacin—atherosclerosis	0.00399	0.0041	CcSEcCtD
Procaine—Nausea—Ezetimibe—atherosclerosis	0.00396	0.00406	CcSEcCtD
Procaine—Diarrhoea—Pravastatin—atherosclerosis	0.00393	0.00404	CcSEcCtD
Procaine—Dizziness—Niacin—atherosclerosis	0.00386	0.00396	CcSEcCtD
Procaine—Dizziness—Pravastatin—atherosclerosis	0.0038	0.0039	CcSEcCtD
Procaine—Nausea—Simvastatin—atherosclerosis	0.00377	0.00387	CcSEcCtD
Procaine—Vomiting—Niacin—atherosclerosis	0.00371	0.00381	CcSEcCtD
Procaine—Rash—Niacin—atherosclerosis	0.00368	0.00378	CcSEcCtD
Procaine—Dermatitis—Niacin—atherosclerosis	0.00368	0.00377	CcSEcCtD
Procaine—Vomiting—Pravastatin—atherosclerosis	0.00365	0.00375	CcSEcCtD
Procaine—Rash—Pravastatin—atherosclerosis	0.00362	0.00372	CcSEcCtD
Procaine—Dermatitis—Pravastatin—atherosclerosis	0.00362	0.00372	CcSEcCtD
Procaine—Nausea—Niacin—atherosclerosis	0.00347	0.00356	CcSEcCtD
Procaine—Nausea—Pravastatin—atherosclerosis	0.00341	0.0035	CcSEcCtD
Procaine—Clomifene—ESR1—atherosclerosis	0.00241	0.716	CrCbGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—PLA2G7—atherosclerosis	0.00134	0.0593	CbGpPWpGaD
Procaine—Probenecid—ALB—atherosclerosis	0.000953	0.283	CrCbGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GHRL—atherosclerosis	0.000782	0.0346	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—TNFRSF11B—atherosclerosis	0.000611	0.027	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—atherosclerosis	0.000471	0.0208	CbGpPWpGaD
Procaine—HTR3A—Ion channel transport—TRPV1—atherosclerosis	0.000424	0.0187	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—atherosclerosis	0.000402	0.0178	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—atherosclerosis	0.000389	0.0172	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000382	0.0169	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.00037	0.0164	CbGpPWpGaD
Procaine—BCHE—Glycerophospholipid biosynthesis—PLA2G2A—atherosclerosis	0.000326	0.0144	CbGpPWpGaD
Procaine—BCHE—Glycerophospholipid biosynthesis—PLA2G1B—atherosclerosis	0.000287	0.0127	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—AGT—atherosclerosis	0.000284	0.0126	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00026	0.0115	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000239	0.0106	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000229	0.0101	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PLA2G2A—atherosclerosis	0.000227	0.0101	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—GHRL—atherosclerosis	0.000216	0.00955	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—ACE—atherosclerosis	0.000209	0.00925	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—FABP4—atherosclerosis	0.000204	0.00901	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.0002	0.00887	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PLA2G1B—atherosclerosis	0.0002	0.00886	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—atherosclerosis	0.000183	0.0081	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000181	0.008	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—IL1B—atherosclerosis	0.000178	0.00786	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000164	0.00726	CbGpPWpGaD
Procaine—SLC6A3—Dopaminergic Neurogenesis—STAT3—atherosclerosis	0.000157	0.00693	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000147	0.00652	CbGpPWpGaD
Procaine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—atherosclerosis	0.000145	0.00643	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000143	0.00633	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000142	0.00628	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000138	0.00609	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000134	0.00595	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—AGT—atherosclerosis	0.000133	0.00586	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—LEP—atherosclerosis	0.00013	0.00575	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—TNF—atherosclerosis	0.000129	0.0057	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—MAPK3—atherosclerosis	0.000126	0.00559	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000117	0.00516	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000117	0.00516	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000113	0.00502	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—INS—atherosclerosis	0.000111	0.00491	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00011	0.00485	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000109	0.00481	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—HMOX1—atherosclerosis	0.000108	0.00477	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ADIPOQ—atherosclerosis	0.000107	0.00475	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—IGF1—atherosclerosis	0.000107	0.00475	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—PRKCG—atherosclerosis	0.000105	0.00467	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000105	0.00465	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000105	0.00465	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTM1—atherosclerosis	0.000101	0.00445	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	9.81e-05	0.00434	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—AGER—atherosclerosis	9.69e-05	0.00429	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PLAT—atherosclerosis	9.26e-05	0.0041	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	9.21e-05	0.00408	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	8.9e-05	0.00394	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	8.66e-05	0.00383	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	8.66e-05	0.00383	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—PDGFB—atherosclerosis	8.65e-05	0.00383	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG1—atherosclerosis	8.6e-05	0.0038	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	8.5e-05	0.00376	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	8.35e-05	0.0037	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—LPL—atherosclerosis	7.96e-05	0.00352	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CG—atherosclerosis	7.95e-05	0.00352	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PLG—atherosclerosis	7.87e-05	0.00348	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.8e-05	0.00345	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	7.72e-05	0.00342	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—TNF—atherosclerosis	7.63e-05	0.00338	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—PRKCG—atherosclerosis	7.6e-05	0.00336	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CD36—atherosclerosis	7.56e-05	0.00335	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP2—atherosclerosis	7.48e-05	0.00331	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—PRKCG—atherosclerosis	7.46e-05	0.0033	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	7.32e-05	0.00324	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	7.32e-05	0.00324	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	7.32e-05	0.00324	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	7.32e-05	0.00324	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.27e-05	0.00321	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	7.23e-05	0.0032	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARA—atherosclerosis	7.03e-05	0.00311	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.01e-05	0.0031	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	6.98e-05	0.00309	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PLA2G7—atherosclerosis	6.98e-05	0.00309	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—APOB—atherosclerosis	6.96e-05	0.00308	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.75e-05	0.00299	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	6.69e-05	0.00296	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—LEP—atherosclerosis	6.67e-05	0.00295	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	6.44e-05	0.00285	CbGpPWpGaD
Procaine—BCHE—Metabolism—LDLRAP1—atherosclerosis	6.37e-05	0.00282	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	6.22e-05	0.00275	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.16e-05	0.00272	CbGpPWpGaD
Procaine—BCHE—Metabolism—PLTP—atherosclerosis	5.99e-05	0.00265	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.87e-05	0.0026	CbGpPWpGaD
Procaine—BCHE—Neuronal System—PRKCG—atherosclerosis	5.82e-05	0.00258	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARG—atherosclerosis	5.81e-05	0.00257	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—PRKCG—atherosclerosis	5.71e-05	0.00253	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—INS—atherosclerosis	5.7e-05	0.00252	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—HSPD1—atherosclerosis	5.67e-05	0.00251	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP9—atherosclerosis	5.62e-05	0.00249	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.55e-05	0.00245	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.51e-05	0.00244	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.51e-05	0.00244	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.48e-05	0.00242	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.35e-05	0.00237	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP2—atherosclerosis	5.34e-05	0.00236	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCG8—atherosclerosis	5.19e-05	0.0023	CbGpPWpGaD
Procaine—BCHE—Metabolism—LTA4H—atherosclerosis	5.19e-05	0.0023	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.13e-05	0.00227	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—atherosclerosis	5.05e-05	0.00223	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CETP—atherosclerosis	5e-05	0.00221	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.84e-05	0.00214	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MAPK3—atherosclerosis	4.77e-05	0.00211	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—F7—atherosclerosis	4.57e-05	0.00202	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.4e-05	0.00195	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ALB—atherosclerosis	4.36e-05	0.00193	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.31e-05	0.00191	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCG1—atherosclerosis	4.1e-05	0.00182	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFB1—atherosclerosis	4.1e-05	0.00181	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—ALB—atherosclerosis	4.08e-05	0.00181	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GHRL—atherosclerosis	4.08e-05	0.0018	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP9—atherosclerosis	4.01e-05	0.00177	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NFKB1—atherosclerosis	3.97e-05	0.00176	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACE—atherosclerosis	3.95e-05	0.00175	CbGpPWpGaD
Procaine—BCHE—Metabolism—FABP4—atherosclerosis	3.86e-05	0.00171	CbGpPWpGaD
Procaine—BCHE—Metabolism—LCAT—atherosclerosis	3.86e-05	0.00171	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA4—atherosclerosis	3.79e-05	0.00168	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLG—atherosclerosis	3.74e-05	0.00166	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP7A1—atherosclerosis	3.72e-05	0.00165	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—atherosclerosis	3.6e-05	0.00159	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—STAT3—atherosclerosis	3.57e-05	0.00158	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	3.55e-05	0.00157	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.55e-05	0.00157	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—atherosclerosis	3.49e-05	0.00154	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PLG—atherosclerosis	3.47e-05	0.00153	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.45e-05	0.00153	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP27A1—atherosclerosis	3.44e-05	0.00152	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MAPK3—atherosclerosis	3.41e-05	0.00151	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.39e-05	0.0015	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—APOB—atherosclerosis	3.31e-05	0.00146	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TGFB1—atherosclerosis	3.31e-05	0.00146	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.3e-05	0.00146	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA2—atherosclerosis	3.26e-05	0.00144	CbGpPWpGaD
Procaine—BCHE—Metabolism—PLA2G2A—atherosclerosis	3.26e-05	0.00144	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALOX5AP—atherosclerosis	3.26e-05	0.00144	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALOX15—atherosclerosis	3.26e-05	0.00144	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCG5—atherosclerosis	3.22e-05	0.00142	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.22e-05	0.00142	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGF2—atherosclerosis	3.16e-05	0.0014	CbGpPWpGaD
Procaine—BCHE—Metabolism—LPA—atherosclerosis	3.11e-05	0.00138	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TNF—atherosclerosis	3.09e-05	0.00137	CbGpPWpGaD
Procaine—BCHE—Metabolism—BGN—atherosclerosis	3.01e-05	0.00133	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.99e-05	0.00132	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA5—atherosclerosis	2.98e-05	0.00132	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.9e-05	0.00128	CbGpPWpGaD
Procaine—BCHE—Metabolism—PLA2G1B—atherosclerosis	2.87e-05	0.00127	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.84e-05	0.00126	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.81e-05	0.00124	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.81e-05	0.00124	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.79e-05	0.00123	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALOX5—atherosclerosis	2.77e-05	0.00123	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.62e-05	0.00116	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.56e-05	0.00113	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP1—atherosclerosis	2.53e-05	0.00112	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—AGT—atherosclerosis	2.5e-05	0.00111	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—atherosclerosis	2.49e-05	0.0011	CbGpPWpGaD
Procaine—BCHE—Metabolism—NAMPT—atherosclerosis	2.49e-05	0.0011	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.47e-05	0.00109	CbGpPWpGaD
Procaine—BCHE—Metabolism—LIPC—atherosclerosis	2.47e-05	0.00109	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOC3—atherosclerosis	2.46e-05	0.00109	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LEP—atherosclerosis	2.45e-05	0.00108	CbGpPWpGaD
Procaine—BCHE—Metabolism—LDLR—atherosclerosis	2.44e-05	0.00108	CbGpPWpGaD
Procaine—BCHE—Metabolism—CETP—atherosclerosis	2.38e-05	0.00105	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—F2—atherosclerosis	2.31e-05	0.00102	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT1—atherosclerosis	2.3e-05	0.00102	CbGpPWpGaD
Procaine—BCHE—Metabolism—SCARB1—atherosclerosis	2.28e-05	0.00101	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.22e-05	0.000983	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMGCR—atherosclerosis	2.16e-05	0.000954	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—INS—atherosclerosis	2.09e-05	0.000927	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ALB—atherosclerosis	2.07e-05	0.000918	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CCL2—atherosclerosis	2.06e-05	0.000912	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGF1—atherosclerosis	2.03e-05	0.000896	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP2—atherosclerosis	1.96e-05	0.000868	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.94e-05	0.00086	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCA1—atherosclerosis	1.92e-05	0.00085	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMOX1—atherosclerosis	1.65e-05	0.000729	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	1.63e-05	0.000721	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOB—atherosclerosis	1.58e-05	0.000699	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM1—atherosclerosis	1.54e-05	0.00068	CbGpPWpGaD
Procaine—BCHE—Metabolism—LPL—atherosclerosis	1.51e-05	0.000667	CbGpPWpGaD
Procaine—BCHE—Metabolism—GPX1—atherosclerosis	1.47e-05	0.000651	CbGpPWpGaD
Procaine—BCHE—Metabolism—CD36—atherosclerosis	1.43e-05	0.000634	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTHFR—atherosclerosis	1.36e-05	0.000601	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARA—atherosclerosis	1.33e-05	0.000589	CbGpPWpGaD
Procaine—BCHE—Metabolism—AGT—atherosclerosis	1.29e-05	0.000571	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOE—atherosclerosis	1.26e-05	0.000559	CbGpPWpGaD
Procaine—BCHE—Metabolism—CAV1—atherosclerosis	1.25e-05	0.000554	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA1—atherosclerosis	1.25e-05	0.000553	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CG—atherosclerosis	1.14e-05	0.000505	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARG—atherosclerosis	1.1e-05	0.000487	CbGpPWpGaD
Procaine—BCHE—Metabolism—INS—atherosclerosis	1.08e-05	0.000478	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALB—atherosclerosis	9.9e-06	0.000438	CbGpPWpGaD
Procaine—BCHE—Metabolism—NOS3—atherosclerosis	9.47e-06	0.000419	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGS2—atherosclerosis	8.66e-06	0.000383	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKT1—atherosclerosis	4.35e-06	0.000193	CbGpPWpGaD
